Penetrium Bioscience

페니트리움바이오 · 187660

Health Care Biotechnology · KOSDAQ

Small-cap

Market cap US$258.4M (₩356.6B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$6.7M

▼ −4.8% YoY

Operating profit · FY2025

−US$5.3M

Loss narrowed

Net income · FY2025

−US$10.7M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$10M(₩13.8B)	US$7.1M(₩9.7B)	US$6.7M(₩9.3B)
Operating profit	−US$2.5M(−₩3.5B)	−US$11.5M(−₩15.9B)	−US$5.3M(−₩7.4B)
Net income	−US$2.4M(−₩3.4B)	−US$14.7M(−₩20.3B)	−US$10.7M(−₩14.8B)

Revenue

Operating profit

Net income

ROE

-68.9%

Debt/Eq

52.3%

Op. margin

-79.5%

Net margin

-159.9%

Rev. YoY

▼ −4.8%

Interactive price history isn't here yet. Would you use it?